AMGN - Teva names Novartis exec to lead US commercial business
2023-09-28 16:30:23 ET
More on Teva, Novartis
- Novartis: Buy This Dividend Aristocrat For Consistent Income
- Teva: Focus On Innovation And Growth Means The Times They Are A Changing
- Eli Lilly benefits as judge overturns $176.5M verdict in Teva patent case
- Novartis readies Sandoz spinoff for trading on Oct. 4
For further details see:
Teva names Novartis exec to lead US commercial business